References
- Warady BA, Ho M. Morbidity and mortality in children with anaemia at initiation of dialysis. Pediatr Nephrol 2003;18:1055–62.
- Wong H, Mylrea K, Feber J, Drukker A, Filler G. Prevalence of complications in children with chronic kidney disease according to KDOQI. Kidney Int 2006;70:585–90.
- Boehm M, Riesenhuber A, Winkelmayer WC, Arbeiter K, Mueller T, Aufricht C. Early erythropoietin therapy is associated with improved growth in children with chronic kidney disease. Pediatr Nephrol 2007;22:1189–93.
- Schafer F. Cardiac disease in children with mild-to-moderate chronic kidney disease. Curr Opin Nephrol Hypertens 2008;17:292–7.
- Staples AO, Wong CS, Smith JM, Gipson DS, Filler G, Warady BA, Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol 2009;4:48–56.
- Amaral S, Hwang W, Fivush B, Frankenfield D, Furth S. Association of mortality and hospitalization with achievement of adult hemoglobin targets in adolescents maintained on hemodialysis. J Am Soc Nephrol 2006;17:2878–85.
- KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 2007;50:471–530.
- Schroeder C. The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee. Pediatr Nephrol 2003;18:805–9.
- Stivelman JC. Refractoriness to recombinant human epoetin (rHuEPO) treatment. In Nissenson AR, Fine RN, editors. Handbook of dialysis therapy. Philadelphia, PA: Saunders Elsevier; 2008. p 812–31.
- Lewis M, Shaw J, Reid C, Evans J, Webb N, Verrier-Jones K. Aspects of anaemia management in children with established renal failure (chapter 15). Nephrol Dial Transplant 2007;22(Suppl 7):vii181–3.
- Frankenfield DL, Neu AM, Warady BA, Fivush BA, Johnson CA, Brem AS. Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project. Kidney Int 2003;64:1120–4.
- Koshy SM, Geary DF. Anemia in children with chronic kidney disease. Pediatr Nephrol 2008;23:209–19.
- Bamgbola OF, Kaskel FJ, Coco M. Analyses of age, gender and other risk factors of erythropoietin resistance in pediatric and adult dialysis cohorts. Pediatr Nephrol 2009;24:571–9.
- Chavers BM, Roberts TL, Herzog CA, Collins AJ, St Peter WL. Prevalence of anemia in erythropoietin-treated pediatric as compared to adult chronic dialysis patients. Kidney Int 2004;65:266–73.
- Atkinson MA, Martz K, Warady BA, Neu AM. Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. Pediatr Nephrol 2010;25:1699–706.
- Seeherunvong W, Rubio L, Abitbol CL, Montané B, Strauss J, Diaz R, Identification of poor responders to erythropoietin among children undergoing hemodialysis. J Pediatr 2001;138:710–14.
- Frankenfield DL, Neu AM, Warady BA, Fivush BA, Johnson CA, Brem SA. Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project. Kidney Int 2003;64:1120–4.
- Port RE, Kiepe D, Van GM, Jelliffe RW, Mehls O. Recombinant human erythropoietin for the treatment of renal anaemia in children: no justification for bodyweight-adjusted dosage. Clin Pharmacokinet 2004;43:57–70.
- Port RE, Mehls O. Erythropoietin dosing in children with chronic kidney disease: based on body size or on hemoglobin deficit? Pediatr Nephrol 2009;24:435–7.
- van Damme-Lombaerts R, Broyer M, Businger J, Baldauf C, Stocker H. A study of recombinant human erythropoietin in the treatment of anaemia of chronic renal failure in children on haemodialysis. Pediatr Nephrol 1994;8:338–42.
- Gagnadoux MF, Loirat C, Bertheleme JP, Maisin A, Kamoun A, Dabout D, Treatment of anemia in hemodialyzed children using recombinant human erythropoietin (Eprex). Results of a French multicenter clinical trial]. Nephrologie 1994;15:207–11.
- Druecke T. RHuEPO hyporesponsiveness – who and why? Nephrol Dial Transplant 1995;10:62–8.